Evidence map›Paper›PMID 42127152›Full record

ArticlePloS one2026

Methods for analytical validation of novel digital clinical measures: A simulation study.

Simon Turner, Chen Chen, Rolando Acosta, Rachell Chon, Eric J Daza, Lysbeth Floden, Joss Langford, Leif Simmatis, Berend Terluin, Benjamin Vandendriessche and 1 more

Abstract readValidation Study
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Simon TurnerDigital Medicine Society (DiMe), Boston, Massachusetts, United States of America.ORCID https://orcid.org/0009-0002-3801-1875
Chen ChenVerily Life Sciences, South San Francisco, California, United States of America.
Rolando AcostaRegeneron Pharmaceuticals Inc., Tarrytown, New York, United States of America.
Rachell ChonCollege of Osteopathic Medicine, Rocky Vista University, Utah, United States of America.ORCID https://orcid.org/0009-0008-0437-0080
Eric J DazaStats-of-1, Menlo Park, California, United States of America.ORCID https://orcid.org/0000-0002-8376-1600
Lysbeth FlodenEvinova, Waltham, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-0584-6227
Joss LangfordActivinsights Ltd., Kimbolton, United Kingdom.ORCID https://orcid.org/0000-0002-3204-5866
Leif SimmatisDepartment of Speech-Language Pathology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Berend TerluinDepartment of General Practice, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Benjamin VandendriesscheDigital Medicine Society (DiMe), Boston, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-0672-0327
Piper FromyDigital Medicine Society (DiMe), Boston, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analytical validation is a crucial step in the evaluation of algorithms that process data from sensor-based digital health technologies (sDHTs). Analytical validation of novel digital measures can be complicated when reference measures with directly comparable units are not available. To address this, we conducted a simulation study. Data was simulated assuming a latent physical ability trait, indirectly accessed through an sDHT-derived target measure collecting step count data, and the items of a clinical outcome assessment (COA) measuring self-reported physical activity. We quantified the ability of two methods to assess the latent relationship between reference and target measures: the Pearson Correlation Coefficient (PCC) and factor correlations from a two-factor confirmatory factor analysis (CFA) model. Additionally, three multiple linear regression models were used to evaluate if multiple COA reference measures can more completely represent a target measure of interest. Our findings show that PCC was more stable, easier to compute, and relatively robust with respect to violations of parametric assumptions than CFA, particularly with small sample sizes. However, CFA was less biased than PCC in all scenarios investigated. We demonstrate that using both PCC and CFA generates more confidence in the results of a target and reference measure comparison. Finally, regression results suggest that incorporating multiple reference measures with more frequent collection time points can provide a more complete presentation of the sDHT's analytical validity. Novel digital measures are being developed at an accelerating pace and promise to revolutionize patient care and medical product development. Our findings provide investigators with crucial information for choosing appropriate methods to perform rigorous analytical validation of these novel measures, including an open-access simulation toolkit.

Indexed as

Computer SimulationDigital HealthAlgorithmsFactor Analysis, StatisticalHumansLinear Models

Identifiers

PMID42127152
PMCPMC13170969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.